Seven major alternative asset managers are trading at extreme oversold levels (RSI 10-31) while simultaneously reporting record operational metrics. Every name beat earnings estimates, posted record AUM/fundraising in Q4 2025, and guided for acceleration in 2026. Yet the entire sector sold off 8-31% over one month on AI/software disruption fears following Anthropic's legal AI tool launch Feb 3.

This is sector-wide dislocation, not company-specific deterioration. Near-term catalyst: Carlyle (CG) shareholder update Feb 26, where management will announce multi-year financial targets after massively beating 2025 guidance.

The Sector Pattern

Uniform oversold while reporting records:

Every management team is guiding for continued acceleration in 2026 while the market prices "alt AM earnings peaked." The selloff appears driven by three factors:

1. AI/software disruption fears — Anthropic legal AI tool launch triggered concerns about software PE portfolio writedowns
2. Performance fee normalization — ARES missed EPS 14% on lumpy performance fees (not fundamentals), similar pattern across STEP/BX
3. Macro/tariff risk repricing — Indiscriminate selling pressure on levered risk assets

None of these address the core secular drivers: Private markets scaling into wealth/insurance channels, credit platform buildout, $29B+ in AUM not yet paying fees converting to management fees as capital deploys.

Near-Term Catalyst: CG Feb 26

Carlyle CEO Harvey Schwartz deferred virtually every forward-looking question on the Q4 call to the Feb 26 shareholder update, saying "multi-year financial targets" and "strategic direction" will be shared. Given CG just beat its $40B fundraising target with $54B actual (+35%), new multi-year targets could meaningfully reset expectations across the entire alt manager complex.

Why this matters for the sector: CG is the first major alt manager to hold a forward-looking strategy event during this selloff. If they announce aggressive multi-year targets while trading at 10.8x forward P/E with record fundamentals, it could trigger re-rating across the group.

TPG as Case Study

TPG exemplifies the sector pattern: deeply oversold on stellar fundamentals.

Q4 2025 operational records:

• $51B capital raised in 2025 (+71% YoY), guiding $50B+ for 2026
• $303B total AUM (+23% YoY), $170B fee-earning AUM (+20%)
• FRE $953M (+25% YoY), margin expanding from 45% to 47% guide
• $29B AUM not yet paying fees — embedded $250M+ annual management fees as capital deploys
• 31% FRE CAGR since IPO, tripled AUM in 4 years

Jackson Financial strategic partnership (closing Q1 2026):

• TPG invests $500M in Jackson (6.5% stake)
• Structured with minimum $4B FAUM after 2 years, $12B by year 5
• Focus on investment-grade ABF and direct lending
• "Long duration, highly predictable fee revenue"

Private wealth momentum:

• T-POP expected to "more than double" in 2026
• Already generated $1.5B inflows in January alone
• 23% inception-to-date return, on 40+ platforms globally

Stock reaction: Down 17% in one month to $55, RSI 22.6. Goldman called selloff "overdone" on Feb 5. Analyst mean target $71 (+29% upside).

What the Market Missed

The embedded fee revenue is mechanical. $29B in AUM not yet paying fees converts to ≈$250M annual management fees as capital deploys — this happens regardless of market sentiment. In credit alone, that's $130M annual fees waiting to turn on. Combined with the contractual Jackson partnership ($4B→$12B FAUM locked in) and T-POP's doubling trajectory, near-term FRE growth is about as visible as it gets for an alt manager.

The AI/software fear is sector contagion. TPG's software exposure is 18% of PE AUM, 2% of credit (≈11% total). They were major net sellers 2020-2022 at peak valuations. Current exposure is mostly in Funds 8/9/10 where AI risk was underwritten during diligence. Their framework: vertical software with proprietary data (AI opportunity) vs horizontal apps (AI risk). Portfolio examples: Lyric (medical claims data, AI driving revenue acceleration), Delinea (identity cybersecurity, net beneficiary).

Performance fee lumpiness is timing, not fundamentals. ARES, STEP, BX all showed the same pattern — lumpy incentive fees normalizing after strong 2024. TPG's realized performance allocations dropped 54% Q4/Q4 ($105M→$48M), but this reflects exit environment timing, not fundraising/deployment deterioration. Management fees (recurring engine) are accelerating.

Honest Limitations

TPG-specific:

1. Valuation framing: The "14.6x forward P/E" cited by analysts is non-GAAP distributable earnings on Class A shares only, excluding $814M/yr equity-based comp. GAAP diluted P/E ≈122x. This is standard for alt managers (BX/KKR/ARES have the same structure), but TPG isn't uniquely cheap on GAAP — it's fairly valued within the DE-based peer set.

2. No insider buying signal: Every Jan 13 transaction was equity comp vesting, not open market purchases. If management genuinely believed $55 was a screaming buy, they'd be in the open market. They aren't.

3. Software exposure understated: 18% of PE AUM ignores Growth platform, TTAD ($7.7B tech-adjacencies), and Rise Climate's tech infrastructure bets. Total firm tech/software-adjacent exposure is materially higher than 11% of total AUM. Of the major alt managers, TPG likely has the MOST software/tech exposure, making it arguably the most vulnerable to the specific fear driving this selloff.

4. Declining realizations: Realized performance allocations dropped 54% Q4/Q4 — a leading indicator of PE exit environment deterioration. This is the structural concern driving the sector selloff. TPG didn't address whether this impacts fundraising momentum for upcoming vintages.

The Cross-Ticker Signal

The sector dislocation thesis is stronger than any single-name thesis. Evidence across multiple alt managers shows:

• Blackstone (BX): Record DE beat 14%, private credit secular shift accelerating, insurance AUM +18% — still sold off
• Ares (ARES): Record $113B fundraising, AUM +29%, management fees +27%, 20% dividend hike — sold off 23.6% on performance fee timing miss
• Carlyle (CG): Beat $40B fundraising target with $54B, record FRE/margins/AUM — Feb 26 event will reset multi-year targets
• Blue Owl (OWL): Record fundraising — RSI 10.5, most oversold in the group
• StepStone (STEP): FRE +20% — RSI 22.7

Every alt manager is reporting operational records while trading at multi-year lows. The question isn't "is TPG cheap?" — it's "which alt manager offers the best risk/reward in the recovery?"

Sizing Implications

Sector basket likely better than single-name concentration:

The pattern is sector-wide (operational fundamentals divorced from price), the catalyst is sector-level (CG Feb 26 event), and the risk is sector-level (AI disruption fears, realization environment, macro). A basket weighted by:

• Quality (recurring fee growth, margin trajectory)
• Software exposure (lower = less vulnerable to current fear)
• Valuation (DE-based P/E, embedded value as % of market cap)
• Catalyst proximity (CG Feb 26, upcoming strategy events)

May offer better risk/reward than concentrated TPG.

If forced to rank single names:

1. CG — Cheapest valuation (10.8x forward P/E), $23/share embedded value (39% of market cap), near-term catalyst Feb 26, credit platform buildout closing gap with ARES/OWL
2. ARES — Largest drawdown (-31%) creates most upside if sector recovers, best-in-class credit franchise, but highest beta (2.04 for CG, likely similar for ARES)
3. TPG — Most embedded fee revenue visibility ($29B ANYPF), Jackson partnership locked in, but highest software exposure = most vulnerable to current fear

What's needed before concentrated single-name sizing:

• Factor regression against alt manager peers (determine true idio alpha vs sector beta)
• Bear case analysis: Do software writedowns impair fundraising for upcoming vintages?
• Catalyst timeline: When does selling pressure exhaust? (RSI <10 for KKR/OWL suggests capitulation may be near)

Verdict

Sector dislocation thesis is real and actionable. Entire alt manager complex at extreme oversold (RSI 10-31) while reporting record operational metrics and guiding for 2026 acceleration. Near-term catalyst Feb 26 (CG shareholder update) with potential for sector re-rating.

Recommended approach: Sector basket weighted by quality/valuation/software exposure rather than concentrated single-name bet. The signal is sector-level, the catalyst is sector-level, the risk is sector-level.

If initiating TPG specifically: Embedded fee revenue provides mechanical downside protection, but highest software exposure makes it most vulnerable to the fear driving selloff. Size accordingly — this is a sector beta play with idio risk skewed negative (software writedown risk), not positive idio alpha.

Watch CG Feb 26. If multi-year targets reset expectations materially higher after beating 2025 guide by 35%, entire sector could re-rate.